Similar results were observed in other human cancer lines after treatment with GANT61, with inventoried GLI assays demonstrating a reduction in gene and protein expression of the target genes GLI1 and PTCH1, as well as reduced transcriptional production [18]. Here, GLI1 is linked to cancer.